PEREZ, Alessandro
PEREZ, Alessandro
A headlight on liquid biopsies: a challenging tool for breast cancer management
2016-01-01 Massihnia, D.; Perez, A.; Bazan, V.; Bronte, G.; Castiglia, M.; Fanale, D.; Barraco, N.; Cangemi, A.; Di Piazza, F.; Calò, V.; Rizzo, S.; Cicero, G.; Pantuso, G.; Russo, A.
Association of circulating tumor DNA (ctDNA) mutations and circulating miRNAs variations, through liquid biopsy, in Non-Small Cell Lung Cancer (NSCLC) patients.
Perez, A.
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab
2023-04-17 Incorvaia, Lorena; Dimino, Alessandra; Algeri, Laura; Brando, Chiara; Magrin, Luigi; De Luca, Ida; Pedone, Erika; Perez, Alessandro; Sciacchitano, Roberta; Bonasera, Annalisa; Bazan Russo, Tancredi Didier; Li Pomi, Federica; Peri, Marta; Gristina, Valerio; Galvano, Antonio; Giuffrida, Dario; Fazio, Ivan; Toia, Francesca; Cordova, Adriana; Florena, Ada Maria; Giordano, Antonio; Bazan, Viviana; Russo, Antonio; Badalamenti, Giuseppe
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning
2022-05-01 Fanale D.; Pivetti A.; Cancelliere D.; Spera A.; Bono M.; Fiorino A.; Pedone E.; Barraco N.; Brando C.; Perez A.; Guarneri M.F.; Russo T.D.B.; Vieni S.; Guarneri G.; Russo A.; Bazan V.
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS.
Di Piazza, F.; Accurso, V.; Caracciolo, C.; Mulè, L.; Bono, M.; Perez, A.; Castiglia, M.; Calò, V.; Massiccia, D.; Barraco, N.; Cangemi, G.; Maragliano, R.; Listi', A.; Galluccio, N.; Bazan, V.; Siracusa, S.; Russo, A.
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
2022-01-13 Fanale D.; Corsini L.R.; Scalia R.; Brando C.; Cucinella A.; Madonia G.; Dimino A.; Filorizzo C.; Barraco N.; Bono M.; Fiorino A.; Magrin L.; Sciacchitano R.; Perez A.; Russo T.D.B.; Pantuso G.; Russo A.; Bazan V.
CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
2020-01-01 Siragusa, Sergio; Russo, Antonio; Bono, Marco; Perez, Alessandro; Di Piazza, Florinda; Raso, Simona; Sardo, Mariano; Casimio, Paolo; Contrino, Angelo Davide; Mancuso, Salvatrice; Santoro, Marco; Accurso, Vincenzo
Cardiovascular risk in polycythemia vera: Thrombotic risk and survival: Can cytoreductive therapy be useful in patients with low-risk polycythemia vera with cardiovascular risk factors?
2020-01-01 Mancuso S.; Santoro M.; Accurso V.; Agliastro G.; Raso S.; Di Piazza F.; Perez A.; Bono M.; Russo A.; Siragusa S.
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab
2017-01-01 Passiglia, F.; Perez, A.; Listi', A.; Castiglia, M.; Musso, E.; Ancona, C.; Rizzo, S.; Alù, M.; Blasi, L.; Russo, A.
Clinical history of thrombosis before diagnosis of overt myeloproliferative neoplasms in triple negative patients
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study
2022-12-06 Gristina, Valerio; Barraco, Nadia; La Mantia, Maria; Castellana, Luisa; Insalaco, Lavinia; Bono, Marco; Perez, Alessandro; Sardo, Delia; Inguglia, Sara; Iacono, Federica; Cutaia, Sofia; Bazan Russo, Tancredi Didier; Francini, Edoardo; Incorvaia, Lorena; Badalamenti, Giuseppe; Russo, Antonio; Galvano, Antonio; Bazan, Viviana
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications
2019-01-01 Santoro M, Accurso V, Mancuso S, Carlisi M, Raso S, Tarantino G, Di Piazza F, Perez A, Russo A, Siragusa S
Dietary restriction: could it be considered as speed bump on tumor progression road?
2016-01-01 Cangemi, A.; Fanale, D.; Rinaldi, G.; Bazan, V.; Galvano, A.; Perez, A.; Barraco, N.; Massihnia, D.; Castiglia, M.; Vieni, S.; Bronte, G.; Mirisola, M.; Russo, A.
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines
2017-01-01 Perez, A.; DI STEFANO, A.; Castiglia, M.; Sorrentino, M.; Matranga, D.; Grisafi, F.; Corso, C.; Scoarughi, G.; Barbato, G.; Barraco, N.; Calo', V.; DI PIAZZA, F.; Massihnia, D.; Listi', A.; Castellana, L.; Guarini, A.; Insalaco, L.; Bronte, E.; Russo, A.
Effect of gene-gene and gene-environment interactions associated with antituberculosis drug-induced hepatotoxicity
2017-01-01 Chamorro, J.; Castagnino, J.; Aidar, O.; Musella, R.; Frías, A.; Visca, M.; Nogueras, M.; Costa, L.; Perez, A.; Caradonna, F.; de Larrañaga, G.
Effects of Dietary Restriction on Cancer Development and Progression
2017-01-01 Fanale, D.; Maragliano, R.; Perez, A.; Russo, A.
EGFR inhibition in NSCLC: New findings…. and opened questions?
2017-01-01 Passiglia, F.; Listì, A.; Castiglia, M.; Perez, A.; Rizzo, S.; Bazan, V.; Russo, A.
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors
2022-12-29 Dimino, Alessandra; Brando, Chiara; Algeri, Laura; Gristina, Valerio; Pedone, Erika; Peri, Marta; Perez, Alessandro; De Luca, Ida; Sciacchitano, Roberta; Magrin, Luigi; Bazan Russo, Tancredi Didier; Bono, Marco; Barraco, Nadia; Contino, Silvia; La Mantia, Maria; Galvano, Antonio; Badalamenti, Giuseppe; Russo, Antonio; Bazan, Viviana; Incorvaia, Lorena
Farmacogenética de la Tuberculosis: Nuevo modelo de predicción de hepatotoxicidad inducida por fármacos antituberculosis
2017-01-01 Chamorro, JG; Castagnino, JP; Aidar, O; Musella, RM; Frías, A; Visca, M; Nogueras, M; Costa, L; Perez, A; Caradonna, F; Perés, S; de Larranaga, GF
FEASIBILITY OF EGFR EVALUATION IN BLADDER WASHINGS OF PATIENTS AFFECTED BY NON MUSCLE-INVASIVE BLADDER CANCER.
2016-05-07 Serretta, V.; Maida, F.; Gesolfo, C.; Tulone, G.; Cangemi, A.; Perez, A.; Russo, A